title: Response to letter received from Moore and Schug: Thakur et al. Impact of Prolonged-Release Oxycodone/Naloxone on Outcomes Affecting Patients׳ Daily Functioning in Comparison With Extended-Release Tapentadol: A Systematic Review.
authors.affiliation: HERON Commercialization, PAREXEL Consulting, Chandigarh, India.
authors.forename: Deepika
authors.initials: D
authors.lastname: Thakur
authors.affiliation: Napp Pharmaceuticals, Mundipharma International, Cambridge, United Kingdom.
authors.forename: Sara
authors.initials: S
authors.lastname: Dickerson